Company Filing History:

5 out of 525

Ludwig Institute for Cancer Research Limited

patents

Years Active: 1999-2002

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6497879 - Immunogenic compositions of tumor rejection antigen precursor MAGE-10 and an adjuvant (2002-12-24),

2. 6387698 - MAGE-10 encoding CDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof (2002-05-14),

3. 6174692 - MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof (2001-01-16),

4. 6153728 - Isolated tumor rejection antigen precursor MAGE-10 and compositions (2000-11-28),

5. 5908778 - Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, (1999-06-01),

Title: Victor Jongeneel: Innovator in Cancer Research

Introduction

Victor Jongeneel is a prominent inventor based in Epalinges, Switzerland. He has made significant contributions to the field of cancer research, particularly in the development of immunogenic compositions. With a total of 5 patents to his name, Jongeneel's work focuses on advancing the understanding and treatment of cancer.

Latest Patents

Among his latest patents are groundbreaking inventions related to the tumor rejection antigen precursor MAGE-10. These include immunogenic compositions that utilize isolated cDNA molecules encoding MAGE-10, the protein itself, and specific antibodies. His inventions aim to enhance the efficacy of cancer treatments by targeting specific tumor antigens.

Career Highlights

Victor Jongeneel has had a distinguished career at the Ludwig Institute for Cancer Research Limited. His research has been pivotal in the development of innovative therapeutic strategies for cancer patients. His expertise in molecular biology and immunology has positioned him as a leader in his field.

Collaborations

Throughout his career, Jongeneel has collaborated with esteemed colleagues, including Donata Rimoldi and Pierre G Coulie. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and accelerates research advancements.

Conclusion

Victor Jongeneel's contributions to cancer research through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative work continues to inspire advancements in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.